placeholder image
T. J. Kaufmann All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872. 
    Cancer. 2019
    • Contact
    full name
  • T. J. Kaufmann
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration